Merck & Co Inc

NYSE:MRK   9:56:11 AM EDT
+0.33 (+0.40%)
Divestitures / Spin-offs, Mergers / Acquisitions

Merck Announces Acquisition Of Alydia Health On Behalf Of Its Planned Spinoff Of Organon

Published: 03/30/2021 12:13 GMT
Merck & Co Inc (MRK) - Merck Announces Acquisition of Alydia Health on Behalf of Its Planned Spinoff of Organon.
Merck & Co Inc - Organon Has Agreed to Acquire Alydia Health for Up to $240 Million Total Consideration.
Merck & Co Inc - Fifty Million Dollars of Upfront Payment Will Be Paid Prior to Spinoff of Organon.
Merck & Co Inc - $165 Million Will Be Paid by Organon Upon Close of Acquisition.
Merck & Co Inc - Transaction is Expected to Close After Organon Has Spun Off From Merck As a Standalone Publicly Traded Company.